Pathstone Family Office, LLC Cognition Therapeutics Inc Put Options Transaction History
Pathstone Family Office, LLC
- $15.6 Billion
- Q3 2023
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding CGTX
# of Institutions
45Shares Held
6.58MCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA1.24MShares$472,1700.0% of portfolio
-
Alyeska Investment Group, L.P. Chicago, IL500KShares$190,0000.0% of portfolio
-
Geode Capital Management, LLC Boston, MA324KShares$122,9840.0% of portfolio
-
Cm Management, LLC250KShares$95,0000.1% of portfolio
-
American Financial Group Inc205KShares$77,9000.04% of portfolio
About COGNITION THERAPEUTICS INC
- Ticker CGTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 22,710,700
- Market Cap $8.63M
- Description
- Cognition Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of small molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its lead product candidate is CT1812, a sigma-2 receptor antagonist, which is in Phase II clinical tr...